Hemoglobinopathies & Thalassemia
Analytical Speed
6 minutes per sample
Sample Capacity
90 samples continuous load
Model: HLC-723 G8 (Beta-Thal Mode)
HLC-723 G8 ß-Thalassaemia Analysis Mode
Proven laboratory instrument for hemoglobinopathy screening with automated sample identification and robust column chemistry.
Status:
Available for Supply & Installation
Institutional Pricing
Gold standard ion-exchange chromatography methodology aligned with NGSP & IFCC
Includes installation, calibration, operator training, and comprehensive AMC
Prompt delivery of certified cold-chain reagents, columns, and buffers
Overview & Diagnostic Capabilities
The HLC-723 G8 ß-Thalassaemia system is optimized for clinical laboratories conducting hemoglobin electrophoresis and screening programs. It features dedicated elution buffers and a specialized column to resolve overlapping peaks and enable confident clinical reporting.
Brochures & Technical Resources
Download official product documentation, whitepapers, and datasheets.
HLC-723 G8 ß-Thalassaemia Mode Brochure
Brochure • 1.9 MB
Inquiry & Procurement
Inquire About the HLC-723 G8 ß-Thalassaemia Analysis Mode
Submit your institutional details to receive a customized quote, reagent package, and installation schedule.
Related Diagnostic Analyzers
View Category →
HLC-723 G11 ß-Thalassaemia Analysis Mode
Dedicated HPLC solution for the quantitative determination of HbA2, HbF and screening of structural hemoglobinopathies (HbS, HbC, HbD, HbE).